Mascoma Wealth Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-5,000	Closed	-$61.6K	–	514
2023 Q3	$61.6K	Hold	5,000	–	–	0.02%	166
2023 Q2	$61.1K	Hold	5,000	–	–	0.02%	176
2023 Q1	$62K	Hold	5,000	–	–	0.02%	214
2022 Q4	$57.3K	Hold	5,000	–	–	0.02%	214
2022 Q3	$19K	Hold	5,000	–	–	0.01%	334
2022 Q2	$30K	Hold	5,000	–	–	0.01%	303
2022 Q1	$32K	Hold	5,000	–	–	0.01%	323
2021 Q4	$20K	Hold	5,000	–	–	0.01%	334
2021 Q3	$24K	Buy	+5,000	New	+$26.1K	0.01%	277
2021 Q2	–	Sell	-5,000	Closed	-$31K	–	472
2021 Q1	$31K	Buy	+5,000	New	+$35.7K	0.01%	259
2017 Q3	–	Sell	-127	Closed	-$1K	–	429
2017 Q2	$1K	Buy	+127	New	+$2.59K	﹤0.01%	401